Champions Oncology Inc reports results for the quarter ended in July - Earnings Summary

Champions Oncology

08/09/2022 22:01

* Champions Oncology Inc  CSBR.OQ  reported a quarterly
adjusted
loss of 2 cents​​ per share for the quarter ended in July. The
mean expectation of three analysts for the quarter was
for earnings of one cent per share.
    * Revenue rose 22.1% to $13.75 million from a year ago;
analysts
expected $13.19 million. 
    * Champions Oncology Inc's reported EPS for the quarter was
a loss
of 2 cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Champions Oncology Inc shares had fallen by 9.4% this
quarter and lost 13.3% so far this year.
    * The company reported a quarterly loss of $319 thousand.
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data September
8 at 09:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jul. 31 2022      0.01           -0.02          Missed
 Apr. 30 2022      0.03           -0.03          Missed
 Jan. 31 2022      0.03           0.05           Beat
 Oct. 31 2021      0.01           0.02           Beat